Eksempler på bruk av Been studied in patients på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Tarceva has not been studied in patients under the age of 18 years.
Efficacy and safety of Renagel has not been studied in patients with.
Eviplera has not been studied in patients over the age of 65 years.
The use of Protopic ointment under occlusion has not been studied in patients.
Cerdelga has not been studied in patients with hepatic impairment.
Hepatic impairment: The pharmacokinetics of enfuvirtide have not been studied in patients with hepatic impairment.
EDURANT has mainly been studied in patients with normal renal function.
The pharmacokinetics of fosamprenavir in combination with ritonavir has not been studied in patients over 65 years of age.
Humira has not been studied in patients with hepatic or renal impairment.
The pharmacokinetics of LEMTRADA has not been studied in patients aged 55 years and older.
Valsartan has been studied in patients with post myocardial infarction and heart failure.
Trastuzumab emtansine has not been studied in patients with platelet counts.
Amlodipine has been studied in patients with chronic stable angina, vasospastic angina and angiographically documented coronary artery disease. Amlodipine.
The pharmacokinetics of emtricitabine have not been studied in patients with varying degrees of hepatic insufficiency.
AZOPT has not been studied in patients with severe renal impairment(creatinine clearance< 30 ml/min) or in patients with hyperchloraemic acidosis.
The effect of IKERVIS has not been studied in patients with hepatic or renal impairment.
AZOPT has not been studied in patients with hepatic impairment and is therefore not recommended in such patients. .
The safety of Vectibix has not been studied in patients with renal or hepatic impairment.
IKERVIS has not been studied in patients with a history of ocular herpes and should therefore be used with caution in such patients. .
The pharmacokinetics of bosentan have not been studied in patients with Child-Pugh class C hepatic impairment.
Rilpivirine has not been studied in patients with severe hepatic impairment(Child Pugh Class C)(see section 4.2).
The pharmacokinetics of etravirine have not been studied in patients with severe hepatic impairment Child-Pugh Class C.
Cobicistat has not been studied in patients with severe hepatic impairment and is not recommended in these patients. .
Paliperidone has not been studied in patients with severe hepatic impairment.
Pazopanib has not been studied in patients who had a history of haemoptysis, cerebral, or clinically significant gastrointestinal(GI) haemorrhage in the past 6 months.
The pharmacokinetics of fondaparinux has not been studied in patients with severe hepatic impairment see sections 4.2 and 4.4.
Gilenya has not been studied in patients with severe pre-existing hepatic injury(Child-Pugh class C) and should not be used in these patients see section 4.3.
Viramune prolonged-release tablets have not been studied in patients with renal dysfunction and Viramune immediate-release should be used.
Eviplera has not been studied in patients with severe hepatic impairment CPT Score C.
Belatacept has not been studied in patients with PRA> 30%(see section 4.2).